Wealthcare Advisory Partners’s Vanguard Health Care ETF VHT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.27M | Sell |
7,593
-142
| -2% | -$39.5K | 0.04% | 332 |
|
|
2026
Q1 | $2.11M | Buy |
7,735
+16
| +0.2% | +$4.57K | 0.04% | 358 |
|
|
2025
Q4 | $2.22M | Sell |
7,719
-80
| -1% | -$22.4K | 0.04% | 338 |
|
|
2025
Q3 | $2.02M | Sell |
7,799
-8,942
| -53% | -$2.24M | 0.04% | 342 |
|
|
2025
Q2 | $4.16M | Sell |
16,741
-3,461
| -17% | -$855K | 0.09% | 176 |
|
|
2025
Q1 | $5.35M | Buy |
20,202
+144
| +0.7% | +$38.4K | 0.14% | 129 |
|
|
2024
Q4 | $5.09M | Sell |
20,058
-1,780
| -8% | -$480K | 0.14% | 136 |
|
|
2024
Q3 | $6.16M | Sell |
21,838
-803
| -4% | -$223K | 0.18% | 108 |
|
|
2024
Q2 | $6.02M | Buy |
22,641
+1,287
| +6% | +$337K | 0.19% | 93 |
|
|
2024
Q1 | $5.78M | Buy |
21,354
+13,119
| +159% | +$3.45M | 0.19% | 93 |
|
|
2023
Q4 | $2.06M | Buy |
8,235
+732
| +10% | +$173K | 0.08% | 197 |
|
|
2023
Q3 | $1.76M | Sell |
7,503
-283
| -4% | -$69K | 0.08% | 190 |
|
|
2023
Q2 | $1.91M | Sell |
7,786
-38
| -0.5% | -$9.24K | 0.09% | 184 |
|
|
2023
Q1 | $1.87M | Sell |
7,824
-45
| -0.6% | -$10.8K | 0.08% | 188 |
|
|
2022
Q4 | $1.95M | Sell |
7,869
-436
| -5% | -$106K | 0.09% | 163 |
|
|
2022
Q3 | $1.86M | Buy |
8,305
+7,161
| +626% | +$1.71M | 0.11% | 144 |
|
|
2022
Q2 | $269K | Buy |
1,144
+44
| +4% | +$10.6K | 0.02% | 463 |
|
|
2022
Q1 | $280K | Sell |
1,100
-43
| -4% | -$10.6K | 0.02% | 436 |
|
|
2021
Q4 | $305K | Buy |
1,143
+205
| +22% | +$52.3K | 0.02% | 437 |
|
|
2021
Q3 | $232K | Sell |
938
-103
| -10% | -$26.4K | 0.02% | 483 |
|
|
2021
Q2 | $257K | Sell |
1,041
-761
| -42% | -$182K | 0.02% | 456 |
|
|
2021
Q1 | $412K | Buy |
1,802
+25
| +1% | +$5.73K | 0.03% | 327 |
|
|
2020
Q4 | $398K | Sell |
1,777
-280
| -14% | -$59.9K | 0.04% | 271 |
|
|
2020
Q3 | $420K | Buy |
2,057
+74
| +4% | +$15K | 0.05% | 224 |
|
|
2020
Q2 | $382K | Buy |
1,983
+915
| +86% | +$172K | 0.05% | 212 |
|
|
2020
Q1 | $177K | Sell |
1,068
-123
| -10% | -$22.5K | 0.03% | 277 |
|
|
2019
Q4 | $228K | Sell |
1,191
-8
| -0.7% | -$1.44K | 0.03% | 276 |
|
|
2019
Q3 | $201K | Sell |
1,199
-420
| -26% | -$71.9K | 0.03% | 274 |
|
|
2019
Q2 | $282K | Sell |
1,619
-159
| -9% | -$26.8K | 0.04% | 210 |
|
|
2019
Q1 | $307K | Buy |
1,778
+23
| +1% | +$3.9K | 0.05% | 180 |
|
|
2018
Q4 | $282K | Buy |
1,755
+94
| +6% | +$15.9K | 0.05% | 167 |
|
|
2018
Q3 | $300K | Buy |
1,661
+650
| +64% | +$112K | 0.06% | 171 |
|
|
2018
Q2 | $161K | Buy |
1,011
+661
| +189% | +$104K | 0.03% | 249 |
|
|
2018
Q1 | $54K | Sell |
350
-244
| -41% | -$39K | 0.01% | 386 |
|
|
2017
Q4 | $92K | Sell |
594
-17
| -3% | -$2.61K | 0.02% | 274 |
|
|
2017
Q3 | $93K | Buy |
+611
| New | +$91.2K | 0.03% | 221 |
|
Other funds holding VHT
AIA
AAG
CA
CMA
MIM
LFP
MAM
BI
TAM
Wealthcare Advisory Partners's VHT Position: Q2 2026 in Review
Wealthcare Advisory Partners reduced its Vanguard Health Care ETF (VHT) stake by 1.8% in Q2 2026, selling an estimated $39.5K and leaving 7,593 shares worth $2.27M. The position accounts for 0.04% of the portfolio, ranked #332.
Wealthcare Advisory Partners first reported a position in VHT in Q3 2017 and has held it in 36 quarters since. The position peaked at $6.16M in Q3 2024. 225 funds tracked by Wall St. Rank hold VHT as of Q2 2026.
- Wealthcare Advisory Partners held 7,593 shares of Vanguard Health Care ETF worth $2.27M as of Q2 2026.
- Wealthcare Advisory Partners sold 142 Vanguard Health Care ETF shares in Q2 2026, an estimated $39.5K.
- Vanguard Health Care ETF made up 0.04% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #332 holding.
- Wealthcare Advisory Partners first reported a position in Vanguard Health Care ETF in Q3 2017 and has held it in 36 quarters since.
- Wealthcare Advisory Partners's Vanguard Health Care ETF position peaked at $6.16M in Q3 2024.
- 225 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q2 2026.
Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.